Delivery Order SPE2DB22D2206-SPE2DB25FKC71
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $1,228.36. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is set for ultimate completion on August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $1,220.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract ceiling value of $2,186.39. This is a firm fixed-price delivery order with no set-aside designation, indicating open competitive award. The contract is scheduled for ultimate completion on April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a ceiling value of $1,042.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract ceiling value of $3,545.56. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is set for ultimate completion on May 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $5,486.46. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The order is set for ultimate completion on August 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 7, 2025, for the supply of Vyvanse 40 mg capsules (100 count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,161.44 with firm fixed pricing and a completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vyvanse 40 mg capsules (quantity: 100s) with a contract value of $3,121.30 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $2,519.35. This competitively awarded, firm fixed-price delivery order is set to be completed by September 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyvanse 50 mg capsules (100 count) with a contract ceiling value of $1,742.02. This firm fixed-price delivery order is set to be completed by September 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating that the contract was competitively awarded. This delivery order...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC71Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Vyvanse 40 mg capsules (100 count) under a firm fixed price contract with a ceiling value of $1,524.41. This is a non-set-aside award, indicating the contract was competitively awarded without restrictions. The place of performance is AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This delivery order represents one of multiple purchases under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/25/25 |